We have previously shown that the pathologic features of ER+ invasive breast cancers that arise in BRCA1 carriers are significantly different than age-matched sporadic ER+ breast cancers in non-mutation carriers. This evidence concerns the gene BRCA1 and invasive breast carcinoma.